Press Release Sponsored

Crypto Insider: Watch out for Tradecurve Presale, Conflux Struggles to Keep Momentum

Tradecurve

The cryptocurrency market has experienced a notable shift recently, where the selling pressure has resulted in a lot of cryptocurrencies losing value. One of the key cryptocurrencies that have struggled to maintain their momentum as a result of this rapid change is Coinflux. As a result, insiders recommend that investors watch out for the presale-stage project known as Tradecurve, as an anticipated price increase of 40% will occur soon, with a 100x spike at launch.

Conflux Struggles to Keep Momentum

Conflux made waves on social media where on June 28, 2023, they announced how DWF Labs, a global digital asset market maker and a multi-sage Web3 investment firm, has reaffirmed its commitment towards supporting the Conflux ecosystem, where it purchased $18 million worth of CFX tokens.

While this activity seemed impressive on paper, the value of the Conflux cryptocurrency has been on a decline. On June 28, 2023, Conflux traded at $0.213774. During the past week, the low point for Conflux was at $0.213545, while the high point was at $0.267077. During the last 30 days, the cryptocurrency has fallen by 33.4%, and in the last 24 hours, it decreased by just 7%. With this in mind, investors are cautious about making future investments in Conflux and are moving toward other projects. 

Tradecurve and The Potential for Its Presale

Amidst the changing dynamics of the crypto market and the overall caution after Conflux struggled to maintain its momentum, another cryptocurrency has managed to emerge as a winner in the minds of many insiders, and that’s TCRV. This utility token behind the Tradecurve platform has already grown in value by 80% since the start of its presale and has been heavily monitored by analysts who are looking for the next potential blue-chip token..

Tradecurve stands out from competitors such as Binance, Kraken, and Coinbase by fixing some of the key issues that have been a part of the industry since its inception. On top of Tradecurve, users do not have to complete a sign-up KYC (Know Your Customer) procedure, and it allows traders to maintain their anonymity whilst still enjoying a secure trading environment, as it will have 2FA security options. 

Not only that, the Tradecurve team also announced that they would implement  Proof of Reserves (PoR), which significantly increases the transparency and trust among traders and the platform, encouraging the value of TCRV to grow even further.

In regards to the features that can be found on the platform, Tradecurve will provide access to high leverage, beginning at 500;1, with negative balance protection, level-up bonuses, A VIP account system, and more. Tradecurve also offers subscription-based features, such as copy trader for beginners who want to copy the trades of experienced traders and for the ability for traders to utilize Ai-driven trading bots to optimize their portfolio.

At the core of all of this is the TCRV native token, currently undergoing Stage 4 of its presale with a value of $0.018, with a 50% bonus on any deposit made until July 3, 2023. This marks a 20% increase in the weekly chart, and at Stage 4, it will grow by an additional 40% to $0.025.

With this momentum in mind, some experts and insiders have hinted that a 100x growth of the token can occur when it launches and gets listed on Uniswap or another major CEX. Tradecurve can capitalize on numerous markets, such as the OTC derivatives market, valued at $632 trillion in June of 2022, so the long-term growth potential is high. In addition, the team has already raised $2.8 million and plans on onboarding 100,000 new users during the first three months of operation, solidifying Tradecurve’s place in the market even further.

For more information about $TCRV presale tokens:

Website: https://tradecurve.io/ 

Buy presale: https://app.tradecurve.io/sign-up 

Twitter: https://twitter.com/Tradecurveapp 

Telegram: https://t.me/tradecurve_official 

Disclaimer: This is a press release. Coinfomania does not endorse and is not responsible for or liable for any content, accuracy, quality, advertising, products, or other materials on this page. Readers should do their research before taking any actions related to the company stated in the release.